Monday, June 8, 2020

Amplyx Pharmaceuticals Names VPs

San Diego-based biopharmaceuticals developer Amplyx Pharmaceuticals announced today that it has named Chris LeMasters as Chief Operating Officer and Carlos Sattler, M.D., as Senior Vice President, Clinical Development. LeMasters was most recently Chief Business Officer of Mirati Therapeutics, with Sattler previously serving at Halozyme, Sandoz, and Merck. Amplyx is developing therapies for patients with compromised immune systems. The company recently raised $53M more in funding, from Sofinnova Investments, New Enterprise Associates, Lundbeckfonden Ventures, Arix Bioscience, Pappas Capital, RiverVest Venture Partners, 3×5 Partners, BioMed Ventures, Pfizer Inc. and Adage Capital Management